NASDAQ NMS - GLOBAL MARKET · IRIX
+3.37% · +$0.0300 · Vol 292.5K
After hours · updated 16:07:31 ET
IRIDEX Corp

IRIDEX Corp

Health Care
$0.9200
Card
Relationship Map

Follow $IRIX

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $IRIX by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
IRIX
IRIDEX Corp
Mon Oct 12 · session closed · Markets closed · resumes Tue 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

69/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →or $250/yr
Cancel anytime · or Reserve · $79/moor $790/yr
Confidence: MEDIUM · 6 of 6 factors measured · Mon Oct 12 · session closed · Markets closed · resumes Tue 9:30 ET
Share on X →
AI Analysis
Sovereign

Why is IRIX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About IRIDEX Corp
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Listed since
1996
Employees
108
Country
US

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.8837
Day high
$0.9805
Day low
$0.8366
Previous close
$0.8900
52W high
$1.56
-41.03% from high
52W low
$0.6070
33% of range
Market cap
$15.6M
EPS
$-0.2062
Beta
0.11
Shares out
17.6M
Volume
292.5K
0.39× rel vol
Avg volume
743.6K
VWAP
$0.9253
Price history computed in-house
1W
+33.33%
1M
+39.39%
3M
-14.02%
1Y
-11.54%
YTD
-19.30%
SMA 50 $0.7381 · above
SMA 200 $1.07 · below
52W position 33%

IRIX overview

Veridion Score
69
Registered · 2026-10-12
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around IRIX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Public disclosures

Congress activity in IRIX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

IRIX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IRIX in this window.
Lobbying spend

IRIX lobbying filings, year to date.

Registered lobbying filings matched to IRIDEX Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IRIX in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for IRIX.
Veridion by email

Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.